Should the prescription of oral anticancer drugs be restricted?
Rep Pract Oncol Radiother
.
2012 Jul 19;17(4):187-9.
doi: 10.1016/j.rpor.2012.07.003.
eCollection 2012.
Authors
Alfredo Ramos
1
,
José Lopez Torrecilla
2
,
Pedro Lara
3
,
Ismael Herruzo
4
,
Jorge Contreras
4
,
Ana Mañas
5
,
Ferran Guedea
6
;
board of directors of the Spanish Society of Radiation Oncology (SEOR)
Affiliations
1
Hospital Universitario Ramón y Cajal, Madrid, Spain.
2
Hospital General de Valencia, Valencia, Spain.
3
Hospital Universitario de Gran Canaria Dr. Negrín, Canary Islands, Spain.
4
Hospital Regional Universitario Carlos Haya, Málaga, Spain.
5
Hospital de la Paz, Madrid, Spain.
6
Catalan Institute of Oncology, Barcelona, Spain.
PMID:
24377022
PMCID:
PMC3863216
DOI:
10.1016/j.rpor.2012.07.003
No abstract available